South Dakota Investment Council’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.07M Hold
8,573
0.04% 325
2026
Q1
$1.62M Hold
8,573
0.03% 347
2025
Q4
$1.46M Hold
8,573
0.03% 360
2025
Q3
$1.13M Hold
8,573
0.02% 410
2025
Q2
$910K Hold
8,573
0.02% 450
2025
Q1
$1.06M Hold
8,573
0.02% 405
2024
Q4
$1.06M Hold
8,573
0.02% 409
2024
Q3
$955K Hold
8,573
0.02% 434
2024
Q2
$915K Sell
8,573
-10
-0.1% -$1.1K 0.02% 420
2024
Q1
$1.03M Hold
8,583
0.02% 408
2023
Q4
$1.06M Hold
8,583
0.02% 450
2023
Q3
$1.11M Sell
8,583
-329
-4% -$43.8K 0.03% 428
2023
Q2
$1.1M Hold
8,912
0.02% 448
2023
Q1
$1.3M Hold
8,912
0.03% 428
2022
Q4
$1.42M Hold
8,912
0.03% 399
2022
Q3
$1.19M Hold
8,912
0.03% 401
2022
Q2
$1.39M Sell
8,912
-103
-1% -$15.9K 0.03% 379
2022
Q1
$1.4M Sell
9,015
-6,700
-43% -$972K 0.03% 385
2021
Q4
$2M Hold
15,715
0.03% 357
2021
Q3
$2.05M Hold
15,715
0.04% 336
2021
Q2
$2.79M Sell
15,715
-1,200
-7% -$208K 0.05% 286
2021
Q1
$2.78M Buy
16,915
+11,915
+238% +$1.96M 0.05% 306
2020
Q4
$825K Buy
5,000
+3,900
+355% +$581K 0.02% 470
2020
Q3
$157K Buy
+1,100
New +$136K ﹤0.01% 570

Other funds holding JAZZ

South Dakota Investment Council's JAZZ Position: Q2 2026 in Review

South Dakota Investment Council held its Jazz Pharmaceuticals (JAZZ) position steady in Q2 2026 at 8,573 shares worth $2.07M. The position accounts for 0.04% of the portfolio, ranked #325.

South Dakota Investment Council first reported a position in JAZZ in Q3 2020 and has held it in 24 quarters since. The position peaked at $2.79M in Q2 2021. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • South Dakota Investment Council held 8,573 shares of Jazz Pharmaceuticals worth $2.07M as of Q2 2026.
  • South Dakota Investment Council left its Jazz Pharmaceuticals share count unchanged in Q2 2026.
  • Jazz Pharmaceuticals made up 0.04% of South Dakota Investment Council's portfolio in Q2 2026, its #325 holding.
  • South Dakota Investment Council first reported a position in Jazz Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • South Dakota Investment Council's Jazz Pharmaceuticals position peaked at $2.79M in Q2 2021.
  • 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on South Dakota Investment Council's 13F filing for Q2 2026, filed 11 Aug 2026.